Precision formulation.
Pharmaceutical standards.
Skinternal formulations are compounded by licensed Australian pharmacists — not manufactured at scale. Every formulation is built around clinical evidence, using pharmaceutical-grade ingredients, with precise control over dosing and composition.
Medicine made for a clinical purpose — not a mass market.
Pharmaceutical compounding is the preparation of a medicine by a licensed pharmacist — formulated to a defined specification, using pharmaceutical-grade raw materials, for a defined clinical purpose. Compounding pharmacists combine specialised knowledge of pharmacology with precise formulation techniques to produce treatments that cannot be replicated by standardised mass-manufactured products.
Unlike commercially manufactured supplements — which are produced at scale, constrained by the economics of mass production, and formulated for the broadest possible consumer — compounded formulations allow precise control over ingredient selection, dosing and composition. No filler ingredients, no overlap in function, no compromise on the dose the evidence supports.
All Skinternal active ingredients are selected for a documented physiological role relevant to clinical skin practice — not for marketing appeal.
Why compounding produces better clinical outcomes
than manufactured supplements
Most manufactured supplements include active ingredients at doses well below those studied in clinical trials. Compounding allows each ingredient to be specified at the dose the evidence supports — a key clinical advantage that standardised products cannot replicate.
Commercial formulations typically contain flow agents, binders, artificial colours and preservatives required for large-scale manufacturing. Compounded products contain only what the formulation requires — every ingredient earns its place.
Mass market supplements are subject to cost pressures that affect ingredient sourcing. Compounding pharmacies use pharmaceutical-grade raw materials selected for documented purity, potency and bioavailability.
How Skinternal fits in clinical practice
Following procedures such as skin needling, chemical peels or energy-based treatments, topical actives are intentionally reduced to support skin barrier recovery. During these windows, while external inputs are limited, internal physiological processes continue. Skinternal provides a mechanism to support these processes without interfering with post-procedure care protocols.
Formulations align with the full treatment pathway — from preparation through to recovery and ongoing maintenance — by supporting the underlying biological processes associated with skin structure, cellular function and repair. This allows them to sit alongside existing clinical protocols without disruption, providing a consistent internal approach while external treatments are adjusted over time.
Skinternal can be integrated across a broad range of clinical and aesthetic interventions as part of a continuous, supportive care approach — complementing professional treatments by maintaining a consistent level of internal support across the treatment cycle.
Two ways clinics access and supply Skinternal
Clinics can align supply with their preferred model of care and level of personalisation.
Clinics order pre-formulated products through the Skinternal platform and supply them to patients following a practitioner recommendation. These formulations are not positioned as retail products and are intended to be integrated into clinical consultation and treatment planning.
Patients complete a structured digital intake questionnaire. A compounding pharmacist reviews the responses to inform a formulation specific to that patient’s treatment context, skin history and life stage — including a pharmacist consultation to confirm clinical details and ensure appropriateness before compounding on demand.
Clinical benefits
Commercial benefits
Licensed Australian compounding pharmacists
Every Skinternal formulation is compounded by licensed Australian compounding pharmacists — and we partner only with a carefully selected few. This is not mass manufacturing, and it is not open to just any pharmacy. Our compounding partners are chosen deliberately for their pharmaceutical-grade capability, rigorous quality systems and strict adherence to TGA regulatory frameworks, with precise control over ingredient selection, dosing and composition.
Skinternal is developed by Blend Compounding, with every formulation reviewed and approved by a qualified pharmacist before supply to clinics.
Formulated to the highest purity standards — suitable across your patient population without restrictions or exceptions.
Ready to offer Skinternal in your clinic?
View our formulations or place an order through your clinic account.